- Datum24.02.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
AbCellera Biologics Inc. Chart

Charts analysieren
wie die Profis?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse und handle direkt aus dem Chart bei Deinem Broker.
Chart analysieren
AbCellera Biologics Inc. Realtime-Kurs
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
L&S | VK | |||||
Tradegate | VK | |||||
Stuttgart | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
-3,18 %
Intraday
-7,34 %
1 Woche
-14,16 %
1 Monat
3,41 %
Seit Jahresbeginn
-37,53 %
1 Jahr
-65,61 %
3 Jahre
Wikifolio
Passender Service zu AbCellera Biologics Inc.
Webinar zu AbCellera Biologics Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)2,335-5,260
- Jahrestief / Hoch ($)2,755-3,680
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von AbCellera Biologics Inc.
Keine Dividenden verfügbar
Termine von AbCellera Biologics Inc.
- Feb27AbCellera Biologics Inc.Q4 2024 Earnings Release
- Mai13AbCellera Biologics Inc.Q1 2025 Earnings Release
- Aug12AbCellera Biologics Inc.Q2 2025 Earnings Release
Beschreibung
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.